A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|10|1645-1653

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.10, 2015-05, pp. : 1645-1653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2973-2980

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignancies

By Awada Ahmad   Zhang Steven   Gil Thierry   de Valeriola Dominique   Lalami Yassine   De Porre Peter   Piccart-Gebhart Martine J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 991-1003

Informa Healthcare

Access to resources Recommend Favorite

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination with Oral Vinorelbine in Patients with Advanced Solid Malignancies

By  

Oncology Research and Treatment, Vol. 36, Iss. 1-2, 2013-01 ,pp. : 40-45

Karger

Access to resources Recommend Favorite

Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer

By  

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 77-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies

By  

Oncology, Vol. 90, Iss. 1, 2016-0 ,pp. : 10-20

Karger

Access to resources Recommend Favorite